Earlybird Venture Capital

Investment decisions are made by the firm's partners, led by co-founders Hendrik Brandis, Christian Nagel, and Roland Manger, who have been with the firm since its founding in 1997. The partnership structure includes sector-specific leads for the Health fund, whose investment committee operates independently from the generalist Digital West team. The firm has not publicly disclosed a single CIO or centralized investment committee structure.

Earlybird leverages its three-office network across Berlin, London, and Prague combined with deep ties to the German Mittelstand — the country's network of industrial small and medium enterprises. This gives the firm early visibility into enterprise software and industrial tech spinouts from the DACH region. The firm's 25-year track record also provides a referral network from founders of portfolio companies like N26, whose alumni have gone on to launch new ventures across Europe.

Earlybird Venture Capital is an institutional venture capital firm that raises external capital from limited partners, not a family office. The firm manages over €2 billion across multiple fund strategies focused on European technology companies. It is not affiliated with any single family's wealth and operates as a traditional VC general partnership.

Earlybird targets seed and Series A rounds as its primary entry point through its Digital West fund, with reserves to follow on through Series B and beyond when companies perform. The firm's Health fund also enters at early stages in biotech and digital health. Earlybird has historically maintained pro-rata positions into later rounds, co-investing alongside US growth firms when portfolio companies reach Series C and D stages.

Earlybird's Health fund operates with a dedicated team of life sciences investment professionals and its own investment committee, functioning as a distinct strategy under the broader Earlybird partnership umbrella. This separation allows the firm to compete for biotech and digital health deals that require specialized scientific due diligence while sharing operational infrastructure and the Earlybird brand with the generalist technology funds.

Earlybird does not publicly maintain an explicit exclusion list. Based on its disclosed portfolio and stated focus areas, the firm concentrates on enterprise software, AI/ML, fintech, digital health, and mobility. It has not disclosed investments in traditional energy, consumer packaged goods, or real estate, suggesting those sectors fall outside its core mandate.

Earlybird actively co-invests alongside US venture firms, including Sequoia Capital and Accel, particularly when its European portfolio companies raise larger international rounds. The firm acts as a local lead investor in early stages, then brings in US co-investors for growth rounds. Earlybird also welcomes co-investment from limited partners when fund strategy permits, though the firm has not publicly disclosed a formal co-investment program open to external parties.